TherapeuticsMD Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	26	10	26	53	151	358
Market Cap Growth	117.98%	-61.51%	-51.31%	-64.97%	-57.86%	-45.38%
Enterprise Value	26	12	24	148	241	527
Last Close Price	2.26	0.86	2.25	5.59	17.77	60.50
PE Ratio	86.62	-	-	0.47	-	-
PS Ratio	9.34	5.63	19.79	0.76	58.71	5.53
PB Ratio	0.95	0.36	0.88	1.51	-1.61	-2.89
P/TBV Ratio	1.11	0.43	1.11	1.88	-	-
P/FCF Ratio	12.65	13.55	-	-	-	-
P/OCF Ratio	12.65	13.55	-	-	-	-
EV/Sales Ratio	9.13	6.97	18.28	2.12	93.74	8.13
EV/EBITDA Ratio	-	-	-	12.49	-	-
EV/EBIT Ratio	-	-	-	13.89	-	-
EV/FCF Ratio	12.34	16.76	-	-	-	-
Debt / Equity Ratio	0.24	0.26	0.27	0.25	-2.11	-2.00
Debt / EBITDA Ratio	-	-	-	0.63	-	-
Debt / FCF Ratio	3.14	9.80	-	-	-	-
Asset Turnover	0.07	0.04	0.02	0.54	0.02	0.29
Inventory Turnover	-	-	-	-	-	1.61
Quick Ratio	2.18	1.67	1.08	0.81	0.26	1.91
Current Ratio	2.93	2.37	1.72	1.18	0.47	2.17
Return on Equity (ROE)	0.27%	-8.16%	-23.90%	-	-	-
Return on Assets (ROA)	-2.73%	-5.32%	-7.96%	5.13%	-25.48%	-43.12%
Return on Capital Employed (ROCE)	-5.10%	-10.40%	-23.40%	24.40%	85.80%	-126.20%
Earnings Yield	1.15%	-21.99%	-39.89%	211.63%	-114.14%	-51.20%
FCF Yield	7.91%	7.38%	-186.82%	-7.71%	-94.48%	-44.55%
Buyback Yield / Dilution	-1.31%	-10.45%	-11.48%	-17.66%	-44.39%	-11.89%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q